Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2611341000168110 | 4-methylbenzylidene camphor 20 mg / 1 g + octyl methoxycinnamate 75 mg / 1 g + zinc oxide 250 mg / 1 g cream (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2611351000168112 | zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | Is a | zinc oxide + octyl methoxycinnamate + 4-methylbenzylidene camphor | true | Inferred relationship | Some | ||
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has manufactured dose form | cream | true | Inferred relationship | Some | ||
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has unit of use | continuous | true | Inferred relationship | Some | 2102619891 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has Australian BoSS | zinc oxide | true | Inferred relationship | Some | 2102619890 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has intended active ingredient | zinc oxide | true | Inferred relationship | Some | 2102619890 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has intended active ingredient | octyl methoxycinnamate | true | Inferred relationship | Some | 2017686098 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has Australian BoSS | octyl methoxycinnamate | true | Inferred relationship | Some | 2017686098 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has intended active ingredient | 4-methylbenzylidene camphor | true | Inferred relationship | Some | 1143077478 | |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | has Australian BoSS | 4-methylbenzylidene camphor | true | Inferred relationship | Some | 1143077478 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream, 50 g | has MPUU | True | zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | Inferred relationship | Some | 1 |
| Zincstic White Zinc SPF 30+ (4-methylbenzylidene camphor 20 mg / 1 g + octyl methoxycinnamate 75 mg / 1 g + zinc oxide 250 mg / 1 g) cream (trade product unit of use) | Is a | True | zinc oxide 25% + octyl methoxycinnamate 7.5% + 4-methylbenzylidene camphor 2% cream | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR